Genome-wide Association Studies-GWAS
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Diseases of the Liver and Gallbladder
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 2, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Bahram Namjou1, Keith Marsolo2, Todd Lingren2
1Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, United States of America; University of Cincinnati, College of Medicine, Cincinnati, OH, United States of America.
Genetic analysis confirms the UGT1A1 gene cluster significantly influences total serum bilirubin levels in both adults and children. This study identifies key genetic contributors to liver function test variations using electronic health records.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: